Predictions of overall survival (OS) and progression-free survival (PFS) for specific therapeutic interventions in newly diagnosed glioblastoma multiforme (GBM) using Cellworks Singula: myCare-024-04
ASCO Meeting Library, 2022
Cellworks Singula therapy response index (TRI) predicts clinical outcomes for esophageal adenocarcinoma: myCare-004